Medtech company Olympus has collaborated with DuPont de Nemours to develop environmentally responsible packaging solutions for its single-use endotherapeutic devices.
The partnership will see Olympus incorporate DuPont’s Tyvek with renewable attribution (RA) into the sterile packaging of more than 100 categories of single-use devices from 2026.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
The solution, launched in November 2024, is designed to reduce the carbon footprint associated with healthcare packaging.
Tyvek with RA employs a certified mass balance approach that integrates renewable feedstocks, thereby decreasing reliance on fossil fuels and minimising the carbon footprint of medical packaging.
Olympus executive officer and chief technology officer Syed Naveed stated: “As a global medtech company, we recognise our responsibility to advance sustainability without compromising the trust and safety that patients and healthcare professionals expect from us.
“The adoption of Tyvek with Renewable Attribution in our packaging marks a significant step in reducing our carbon footprint while preserving the integrity and safety of our medical devices.”
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataThe initial phase of this collaboration will focus on the introduction of medical device packaging using DuPont Tyvek with RA at Olympus’s manufacturing facilities in Japan and Vietnam.
This will encompass more than 100 single-use device categories, including sampling and therapeutic devices for gastrointestinal and respiratory endoscopes.
The transition to sustainable packaging is projected to reduce carbon emissions by one-third of the total carbon footprint of traditional Tyvek.
Olympus plans to gradually expand the initiative to additional manufacturing sites and product lines in future phases.
David Domnisch, vice-president and general manager of DuPont, stated: “Tyvek with renewable attribution is designed to help reduce the carbon footprint of a product while providing a drop-in solution that can be seamlessly integrated into existing healthcare packaging products.
“We are excited to work with Olympus and help advance sustainability in the healthcare sector.”
